C
CapsoVision, Inc.
CV · NASDAQ · Healthcare · 323M
Price · close
$6.02
+1.86% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
21.3×
Enterprise value / EBITDAEV/EBITDA
-10.9×
Free cash flow yieldFCF yield
-8.1%
Return on equityROE
-190.9%
Operating margin
-188.3%
Net debt / EBITDAbalance-sheet strength
0.4×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.